Delfi Diagnostics

Palo Alto, CA · Founded 2019 · Privately Held (backing)

Developer of a blood test system designed for the early detection of cancer. Delfi Diagnostics is based in Palo Alto, CA and was founded in 2019. Its last reported valuation was $725 million in Jun 2024. It has raised $466 million across 1 recorded round; the latest was a $34.3 million debt round in Dec 2025.

Last reported valuation
$725.0M
Oct 2026
Priced at
—
Total raised
$465.9M
Last round
Debt
Dec 2025
How much has Delfi Diagnostics raised?
$465.9Macross 1 recorded rounds · Dec 2025 – Dec 2025

Most recently, Delfi Diagnostics raised $34.3M in its Debt (Dec 2025).

Free account
More of Delfi Diagnostics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Delfi Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Delfi Diagnostics round by round

1 rounds
Dec 2025Debt$34.3MSEC filing▮
50 investors participated

How much has Delfi Diagnostics raised?

Delfi Diagnostics has raised $466 million in total; 1 of its rounds is on record. The largest on record was a $34.3 million debt round in Dec 2025.

Delfi Diagnostics has filed 1 Form D with the SEC, most recently in Dec 2025 ($34.3 million sold to 50 investors).

Delfi Diagnostics investors

27 investors are on record for Delfi Diagnostics, including Menlo Ventures, OrbiMed, Mirae Asset Capital and Point72 Ventures. By type, the record holds 10 venture capital firms, 1 family office and 1 hedge fund. The debt round in Dec 2025 drew 50 investors.

For fundraisers
Raising for a company like Delfi Diagnostics?

27 investors have backed Delfi Diagnostics.

See all 27 investors →

Frequently asked about Delfi Diagnostics

How much has Delfi Diagnostics raised?
Delfi Diagnostics has raised $465.9M in total across 1 recorded funding rounds.
When was Delfi Diagnostics's last funding round?
Delfi Diagnostics's most recent recorded round was Debt in Dec 2025, raising $34.3M.